<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Darwen Healthlink</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Darwen Healthlink is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0803042U0&amp;denomIds=8.3.4&amp;selectedTab=summary">Enzalutamide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>161</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>26.60</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0803042U0AAABAB&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Enzalutamide 40mg tablets : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Intermediate and long-acting insulins</td>
      <td>542</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>10.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0601012ABBBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 33microg/ml inj 3ml pf SoloStar pens : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0603020K0&amp;denomIds=6.3.2&amp;selectedTab=summary">Methylprednisolone sodium succinate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Use of corticosteroids</td>
      <td>1008</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.13</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAL6ElEQVR4nO2debRd0x3HP5cYQok2VEy1S+kihi6ERZSmSsum1bRYEUOLJkJUKshO0UalbFMNjSFBlgoNlqlhi1WaaLAk1FhDtarbqg6sEvMYTv/47RfX897LPfeee+977/w+a9313jv33PP77eR+z/7tvX/7dypZlqEoSjlYrt0OKIrSOlTwilIiVPCKUiJU8IpSIlTwilIiVPCKUiJU8IpSIlTwilIiVPCKUiJU8IpSIlTwealUNBdZ6bMMaLcDSuMYF1YEpgOHR28/arc/Su9Fe/j+wQ7AD4DhbfZD6eWo4PsHuwEPAAe22xGld6OC7x/sBhwL7J3Ce0XpEhV8H8e48BlgQ2ARcD+we3s9UnozKvi+zy7APdHbDPgtGtYrPaCC7/vsBvwh/T4X2NW4sGob/VF6MSr4vs9SwUdv3wPuAL7dVo+6wbhwgHHhC+32o8yo4PswxoW1gFWit89XHe7NYf3pwFXGheXb7UhZUcH3bUYA8zsd+yOwpXFhcBv86RbjwjrAO8ALwHFtdqe0qOD7NrsBd1UfiN5+CNwEfK8tHnXPcOA+YDww1riwdZv9KSUq+L5NVz089M6wfmfg3ujtq8AYJLRfuc0+lQ4VfB/FuGCAt6K3/+vi7YeAIcaFDVrrVY909PBEb+chE41T2+pRCVHB912ql+M+QVqTvxY4oKUedUNaJlwb+EfV4Z8CexgXRrTHq3Kigu+7dCv4xGx6T1i/PfBAuhEBEL19FzgEmGFcWKNtnpUMFXwfxLhQQcbE93R3TvT2GeBt48I3WuZY9+xMCuerid4+ClwNuJZ7VFJU8HVgXBhiXLjIuLBZD+dUjAvfNC7caVwYWrALQ4Hno7dvLuO8Y4BpxoWBBdvPy3Dg3m7eOx8Ypb18a1DB18cUYHXgJuPCLOPCl6rfNC4MQ5bLJgO/A65Nm1yKYlnhPADR20eAW4FTCrSdi5RksxXwaFfvR29fQ3r5o1vpV1lRwdfHCOAIYEtEeLcbF64wLuxqXLgOuAw4BxgRvZ0G3ABcnELxIvjU+nsPTAG+b1zYqiDbeRkKPBO9/aCHcy4AxhgXVmmRT6VFBV8fU6K370Vvl0RvrwS2QLan/gK4Ddg2eju3apJqKrAu8MNGDRsXBgDbIgUvlkn09i3gx8jkWDtSWpcux3VH9PYl4BbkJqo0ERV8DowLHSWkrqs+Hr19P3o7I3q7a/R2Vsp2q37/Q2A0cJJxYcsG3dgDeDB6+36tH4je3gE8BxzZoO162Jnux+/VnAMcqwU8mosKvkZSOH4WQD2FIqO3LwKHI+P51RpwZSIy0ZWXnwAnGBfWb8B2PeyIFObokejtP5F9AAc13aMSo4Kvne8Arzdygejt3cj6+KX1jOeNC9sAgxBh5LX9InAa8Ou8n60X48J6wJtpYq4WzkRuSrqbrkmo4GsgjZt/CUwq4HKnA0MAW8dnJwLnVCew5GQmMMi4MK7Oz+dlmeP3alLuwJ/pfRt/+g0q+No4DBk3P97ohdJw4HTgqDyfMy5siGSs3dCA7QzYDzjSuNCKLLxcgk+cAbgCVzSUKlTwPWBcWN648EUkE+xnBV56PrBR2gBTK8cC06K3SxoxHL19GfgWcIpxoZDKOD3MC9Q6YbeUlDvwIrBno34pn6aSZfrkJADjwnLAXkjV143Taw2kYMPM6O0lgDxqKssa7n2MCycAg6K3J9dw7hrA48DQ6O0bjdpO1zTIWv6YtHut3usMAxYCZwMnd9yQUqLRk4DJOwQxLuyAPElnu55ucOn/bKfoba6bSpkpfQ9vXBhgXBgFPAKMRdbTTwWGR2/Xid4OWyr2YrkSOMi4sEIN544BrilK7ADR2wjsDVyeBFYvk4GDgc8B84wL66bjOwCL6plviN4uAh5D2t0T44C5xoXzdKKvNkrbwxsXVkJ2ax2P7B/3NY3RC+rhkw+zgRuitzf2cM6KwF+AnaO3/y7CbqfrbwPcCIxM4XSez24OXA9sFb39yLhwMHKzPAIJ51+L3l5Qp1/rIMt523W15z8NteYBX0XmRFYHRqdEo16PcWEs8HT0dkEr7Zayh0/JLw8hk2A2entgERNydTAdiSp6YhRwdzPEDhC9fTjZuNG4sE/Oj08CzurIS4jezgL2AS5EcuPzTthV+/Uf4CJkKfETpAm9y4DJ0dsXgEORCG2+cWFIp3MHGBf2MC6cmyY+2066yZ4A/KaARKxclKqHT1+Uw5Ew9PC0Lp6PYnv4CjLO3Sd6+/du3n8MGBW9fbIImz34shEwB7gCOH9ZoXiaA7gT2Lxznnwavx8NnNvIJGOKbh5Feu5Hqo6PQSb1Rlb7aVw4CJlc3Q8YjBQA2Qt4EHgGWTUY0TkTspWkNi1CCnl+iCyVfi3duJpOaXr49CWchXwJdqpL7AWTvqyXAz/q5pQjgBeaLfbky3NIGL4ncEkNcwvHIzeGT22Kid6+Gb09s4AVhfeR3IMLO5bpUl37ycC4zjel6O3VyL/lHGACsACZ6BwZvZ2MVNw5sRGfCmASsDB6Oz+F8ycBtxkXBrXCeCl6+LRTbHZ6ndHQHb7AHj75Nhh4GNikIz8+fblPRHqqvaO3/y3KXg3+rICE5BsD+6eik53PWRvppTaL3r7TAp/mICW7ZiNP17kmDR/yXmd14E9IxPRQsV7WZH8LZJPQNtHb16uOT0RutHvl2SNRD/26h09FKMYDNwNHR2+ntjOc64q0Lr4A2BeW7h+/EPg6En62TOzJnw+QpKDbgYXGhe27OG0CcGkrxJ44DtlxOB5Yguyfz00S2WFIxdyWbsVN2ZozgfHVYk/8CngKWTFpasJRvxW8cWFNpPjE7sAOvSGE74HpSK32lZGdeIOQcX1hy3B5iN5m0dvzke28s4wLk9Kad0dOwIFAM5Yqu/PnWaSHPw0Y20BqMWnN/mZkd14rmQA8lXYudvYpQzY3rQrcbFzYtllO9EvBpzpui5DnrO3bTSnn3sR9wOeRrLS/Aoc2O7Srhejt/chKxtbA79Ma+1HA1Tk2xBTFL5ClyX8VcK1TgWHGhXr2M+TGuLAp8u/W7RN3UuS5P3ANsrnqrrS6UGiPX/gY3riwB9DhZOefHWRVP7MujnX1XgVYIb0GVP3e+e/NkNnY0dHbJxpvUScKHsN3YFwYCawZvZ1R9LUbJX3pDkGq5wxACny81FanGsS48GVkPmAKsAqwWnp1lCJbDLyaXouBt/n4O7Zi+rkcMsRYAnyQXhmyOWp9YIP08yvAMdHbW2r0rYJUVToR6QhmA28A7yKP63oXeA/4CPgoeltr9SPIsqzQFzCm6Gv2Jnvaxv5hryxt7PxqRki/rHTIvm6vHTa1jf3DZjva+An65RheUZSuUcErSolohuBbPenUjkkubWPft9cOm22fkC1Fpp2iKIKG9IpSIgbkOblSqewC7AS8lGXZzEqlMhLJuX4W2fU1GlmznMbHz/4+CXkQwmeBq7Ise7ZFNqcDTwAzsix7uwn2rkTKRV+aZdnCSqXyc2AgcGaWZYub1MbONq8HFmRZNq1J9uYgySBDsiyb0KI2drbZ7DZehWyv3SDLsuNa1MbONutqYz3k7eF3zLLMA2ulvzfJsuxsYFOkCutUYCUkM+tOpITS1kiiwlRkr3Re6rX5MpKqmHfMUpO9LMteRQRIpVIZjJTCuhxJmGhKG6ttJl4GBlYqlbyJQLXaey6d91YL27jUZova+AoiyMEtbONSmw22MTd5Bd9ZPLWKqTprLi912cyybBLy2Ke8j0uut42NUG8bxyGpuFs0y16lUvkuUnSzUeqy2Yo2Zll2K7KBKVfEW4TNSqWyUgNtzE2uSbsUsuwIvIJs6dwQCVn+BjyNVE5ZzCcrlZyMhPRrALPqDOnrsTkRSW30WZbVnH+dw97FwHlIOuXxyDBiIHBWnaFgXptTkPzs9YBJWZbVXNoph715SHHKO5AHPp7SgjZW27wC2SHXzDbORergr488XvvkFrSx2uZkpFhI7jbWg87SK0qJ0Fl6RSkRKnhFKREqeEUpESp4RSkRKnhFKREqeEUpESp4RSkRKnhFKREqeEUpESp4RSkRKnhFKRH/B92n3dxzMFGkAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0603020K0AAADAD&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Methylprednisolone sodium succinate 1g inj vials : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=100101040&amp;denomIds=10.1.1&amp;selectedTab=summary">Tenoxicam</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>2608</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.00</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=100101040AAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Tenoxicam 20mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0&amp;denomIds=2.6.2&amp;selectedTab=summary">Diltiazem hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1227</td>
      <td>Calcium-channel blockers</td>
      <td>6248</td>
      <td>0.20</td>
      <td>0.05</td>
      <td>0.03</td>
      <td>5.43</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAASAS&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 120mg modified-release tablets : 113</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAUAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 120mg modified-release capsules : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAVAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 180mg modified-release capsules : 106</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAWAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 240mg modified-release capsules : 48</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BBACAS&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem Retard 120mg tablets : 95</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BBADAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem LA 300 capsules : 55</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BBAEAX&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem LA 200 capsules : 50</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFADAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 120mg capsules : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAEAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 180mg capsules : 45</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAFAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 300mg capsules : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAHAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 180mg capsules : 37</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAIAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 240mg capsules : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BJABAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil SR 120 capsules : 62</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BJACAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil SR 180 capsules : 37</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BJAEAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil XL 300 capsules : 40</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BMABAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 120 XL capsules : 49</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BMACAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 180 XL capsules : 40</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BMADAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 240 XL capsules : 37</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BNABAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 180mg capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFACAT&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 90mg capsules : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BJAAAT&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil SR 90 capsules : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAACAC&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 90mg modified-release tablets : 28</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAXAX&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 200mg modified-release capsules : 23</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BBAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem 60mg modified-release tablets : 18</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAGAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 120mg capsules : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BMAAAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 300 XL capsules : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BBABAC&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem Retard 90mg tablets : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 60mg modified-release tablets : 12</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BNAAAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 120mg capsules : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BNAEBA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 360mg capsules : 21</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAAEAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 300mg modified-release capsules : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AABABA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 360mg modified-release capsules : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BNACAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 240mg capsules : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BFAJAX&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 200mg capsules : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0BJADAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil XL 240 capsules : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0206020C0AAATAT&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Diltiazem 90mg modified-release capsules : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where Darwen Healthlink is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0202010P0&amp;denomIds=2.2.1&amp;selectedTab=summary">Indapamide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>268</td>
      <td>Thiazides and related diuretics</td>
      <td>2814</td>
      <td>0.10</td>
      <td>0.42</td>
      <td>0.16</td>
      <td>-2.06</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0202010P0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 2.5mg tablets : 176</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0202010P0AAADAD&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 1.5mg modified-release tablets : 92</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0304010I0&amp;denomIds=3.4.1&amp;selectedTab=summary">Cetirizine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>143</td>
      <td>Antihistamines</td>
      <td>1790</td>
      <td>0.08</td>
      <td>0.28</td>
      <td>0.11</td>
      <td>-1.89</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0304010I0AAAAAA&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Cetirizine 10mg tablets : 86</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0304010I0AAABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Cetirizine 1mg/ml oral solution sugar free : 55</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0304010I0BFABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Piriteze Allergy 1mg/ml syrup : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0&amp;denomIds=4.7.1&amp;selectedTab=summary">Paracetamol</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1092</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>5569</td>
      <td>0.20</td>
      <td>0.48</td>
      <td>0.16</td>
      <td>-1.75</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AAAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 500mg capsules : 56</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AAAMAM&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 500mg tablets : 903</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AAAQAQ&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 500mg soluble tablets : 63</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AAAWAW&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 120mg/5ml oral suspension paediatric sugar free : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AABGBG&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 250mg/5ml oral suspension sugar free : 35</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0407010H0AAACAC&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Paracetamol 250mg/5ml oral suspension : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3871</td>
      <td>Selective beta(2)-agonists</td>
      <td>4681</td>
      <td>0.83</td>
      <td>0.91</td>
      <td>0.05</td>
      <td>-1.73</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 2680</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AAAQAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 200micrograms/dose dry powder inhaler : 44</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 37</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 477</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 343</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 76</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 124</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AABGBG&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2mg/5ml oral solution sugar free : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BMAAAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose inhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0AABZBZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose dry powder inhaler : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BIAFAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose inhaler CFC free (Teva) : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BMABBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose Autohaler : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=0301011R0BWABAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh : 20</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=1202010W0&amp;denomIds=12.2.1&amp;selectedTab=summary">Fluticasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Drugs used in nasal allergy</td>
      <td>618</td>
      <td>0.01</td>
      <td>0.22</td>
      <td>0.13</td>
      <td>-1.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=1202010W0BBAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Avamys 27.5micrograms/dose nasal spray : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81140&amp;numIds=1202010W0AAAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Fluticasone furoate 27.5micrograms/dose nasal spray : 6</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>